Auriacombe M - Search Results

1

Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.

Dematteis M, Auriacombe M, D'Agnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, Daulouede JP, Leonardi C, Maremmani I, Torrens M, Walcher S, Soyka M. Dematteis M, et al. Among authors: auriacombe m. Expert Opin Pharmacother. 2017 Dec;18(18):1987-1999. doi: 10.1080/14656566.2017.1409722. Epub 2017 Dec 3. Expert Opin Pharmacother. 2017. PMID: 29183228 Review.

2

[Sleep disorders and addictions: Impact on quality of life and relapse vulnerability].

Fatseas M, Kervran C, Auriacombe M. Fatseas M, et al. Among authors: auriacombe m. Presse Med. 2016 Dec;45(12 Pt 1):1164-1169. doi: 10.1016/j.lpm.2016.01.022. Epub 2016 Mar 9. Presse Med. 2016. PMID: 26970937 French.

3

Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study.

Dupouy J, Palmaro A, Fatséas M, Auriacombe M, Micallef J, Oustric S, Lapeyre-Mestre M. Dupouy J, et al. Among authors: auriacombe m. Ann Fam Med. 2017 Jul;15(4):355-358. doi: 10.1370/afm.2098. Ann Fam Med. 2017. PMID: 28694272 Free PMC article.

4

Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries.

Fonseca F, Lenahan W, Dart RC, Papaseit E, Dargan PI, Wood DM, Guareschi M, Maremmani I, Auriacombe M, Farré M, Scherbaum N, Torrens M. Fonseca F, et al. Among authors: auriacombe m. Front Psychiatry. 2021 Apr 28;12:676224. doi: 10.3389/fpsyt.2021.676224. eCollection 2021. Front Psychiatry. 2021. PMID: 33995154 Free PMC article.

5

[Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature].

Loustauneau A, Auriacombe M, Daulouede JP, Tignol J. Loustauneau A, et al. Among authors: auriacombe m. Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S31-6. Ann Med Interne (Paris). 2002. PMID: 12518080 Review. French.

6

French field experience with buprenorphine.

Auriacombe M, Fatséas M, Dubernet J, Daulouède JP, Tignol J. Auriacombe M, et al. Am J Addict. 2004;13 Suppl 1:S17-28. doi: 10.1080/10550490490440780. Am J Addict. 2004. PMID: 15204673

7

Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals.

Fatseas M, Denis C, Massida Z, Verger M, Franques-Rénéric P, Auriacombe M. Fatseas M, et al. Among authors: auriacombe m. Biol Psychiatry. 2011 Oct 15;70(8):720-727. doi: 10.1016/j.biopsych.2011.05.015. Epub 2011 Jul 8. Biol Psychiatry. 2011. PMID: 21741031 Clinical Trial.

8

Effectiveness of therapeutic communities: a systematic review.

Malivert M, Fatséas M, Denis C, Langlois E, Auriacombe M. Malivert M, et al. Among authors: auriacombe m. Eur Addict Res. 2012;18(1):1-11. doi: 10.1159/000331007. Epub 2011 Oct 13. Eur Addict Res. 2012. PMID: 21997500 Review.

9

The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.

Fatseas M, Debrabant R, Auriacombe M. Fatseas M, et al. Among authors: auriacombe m. Curr Opin Psychiatry. 2012 May;25(3):219-25. doi: 10.1097/YCO.0b013e3283523d7c. Curr Opin Psychiatry. 2012. PMID: 22449768 Review.

10

Buprenorphine diversion and misuse in outpatient practice.

Lofwall MR, Martin J, Tierney M, Fatséas M, Auriacombe M, Lintzeris N. Lofwall MR, et al. Among authors: auriacombe m. J Addict Med. 2014 Sep-Oct;8(5):327-32. doi: 10.1097/ADM.0000000000000029. J Addict Med. 2014. PMID: 25221985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page